Location: Home
  • search
  • go
  • Relate News
  • 4/6/2018Frontage Acquires CRO Preclinical Concord Biosciences to Expand Offeri...
  • 4/4/2018The State Council Issues New Policy for Reform and Improvement of Gene...
  • 4/3/2018Chinese Investors Acquires 90% of Italy's Oncology Developer NMS Group...
  • 4/3/2018Trump's China Tariff Plan Target Dozens of Key APIs and Medical Device...
  • 4/3/2018Novartis Entangled in New Bribery Allegation, Days After Its CEO Bragg...
  • 4/2/2018CFDA Issues 2017 Food and Drug Regulatory Statistics Annual Report
  • 4/2/2018NDRC: Chinese Pharma Industry Revenues Up 12.2% in 2017
  • 4/2/2018Review of Import New Drugs Approved by the CFDA in 2017
  • 3/30/2018Organization/Jurisdiction of State Medical Insurance Administration Un...
  • 3/30/2018Recent Official and Executive Moves
  • 3/29/2018CDE's Annual Review of Drug Evaluation and Registration in 2017
  • 3/29/2018After A Makeover and Hiring Spree, China's Drug Agency Is Romping and ...
  • 3/29/2018China Fast-tracks IPO by Leading Pharma Outsourcing Firm WuXi AppTec
  • 3/29/2018Biotech Deals Targeted for More Scrutiny in New Trump Administration T...
  • 3/29/2018Beroni Agrees to Fund Novel Anticancer Development of Cystemix
  • 3/27/2018CDE Solicits Feedbacks on Proposed Adjustment of Long Term Stability S...
  • 3/27/2018Agena and Simcere Announce Strategic Partnership for Companion Diagnos...
  • 3/27/2018Novartis CEO Eyes Sharp China Growth on Faster New Drug Approvals
  • 3/26/2018Nicholas Hall Reports 6% Growth for Chinese OTC VMS Market in 2017
  • 3/23/2018Recent Executive Moves
  • 3/23/2018CBT Pharma Licenses CrownBio's CTLA-4 Antibody to Grow Immuno-Oncology...
  • 3/22/2018Allergan Launches RVO Drug Ozurdex in China
  • 3/22/2018Data Snaphot: Chinese Foreign Trade of Medicines and Health Products i...
  • 3/22/2018SemaThera Enters Licensing Deal with Senju Pharma for China and Japan
  • 3/22/2018WuXi Biologics To Install Industry's Largest Single-Use Bioreactor At ...
  • 3/22/2018Promised Import Tariff Reduction on Cancer Drugs by China Expected to ...
  • 3/21/2018China Appoints Key Leaders of State Market Regulatory Administration
  • 3/20/2018Central Government Issues New Document to Deepen Overall Reform of Pub...
  • 3/20/2018Dova Licenses China Rights of Novel Thrombopoietin Receptor Agonist to...
  • 3/16/2018CFDA Issues Pharmaceutical Research Guidance for Phase III Trials of I...
  • Page:176/367 Total number of articles:11001: [First][<<] [174] [175] [176] [177] [178] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group